Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJosip Juraj Strossmayer University of Osijek

About this trial

The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CVD, as well as identify new biomarkers for CVD.

Eligibility criteria

Qualifiers

adult patients of both sexes over 18 years of age

Caucasian

undergoing elective coronary artery bypass grafting (CABG)

provided written informed consent

Disqualifiers

emergency surgery

sepsis or severe systemic inflammation before surgery

severe renal or hepatic insufficiency

immunosuppression

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

35 Participants
are grouped into 1 trial group